NASDAQ: OKYO

The names of the directors and biographical details

Please click on the link below for the names and brief biographical details of each director.

Directors

Board Diversity

Please click on the link below for details of OKYO Pharma’s Board Diversity.

Diversity Matrix

Directors’ responsibilities

Please click on the link below for details on the directors’ responsibilities.

Corporate Governance

Board committees

Please click on the link below for details of OKYO Pharma’s Board committees.

Corporate Governance

Advisers

Please click on the link below for details of OKYO Pharma’s key advisers.

Corporate Directory

Country of incorporation and main country of operation

OKYO Pharma is incorporated and registered in Guernsey with company number 65220. OKYO Pharma’s main country of operation is the United Kingdom. Please click on the link below for the Memorandum and the Articles of Association.

Corporate Documents

Company announcements

Please click on the link below to access notifications made by OKYO Pharma in the past 12 months.

News

Details of any other exchanges or trading platforms

OKYO Pharma is not listed on any other exchanges or trading platforms.

Number of securities in issue

Please click on the link below for details of the number of securities in issue, the number of securities held as treasury shares and, insofar as OKYO Pharma is aware, the percentage of securities that is not in public hands together with the identity and percentage holdings of significant shareholders.

Share Information

Details of any restrictions on the transfer of securities

There are no restrictions on the transfer of securities.

Financial information

Please click on the link below for access to OKYO Pharma’s annual and interim reports.

Corporate Documents

Admission documents and circulars

Please click on the appropriate links below to access:

Corporate Documents

ISIN

Please note that OKYO Pharma’s ISIN number is GG00BMFG5F62 .

CUSIP

Please note that OKYO Pharma’s CUSIP number is G6724L116